89bio Inc (NASDAQ: ETNB) on Tuesday, soared 3.31% from the previous trading day, before settling in for the closing price of $10.57. Within the past 52 weeks, ETNB’s price has moved between $5.99 and $16.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -59.99%. With a float of $138.70 million, this company’s outstanding shares have now reached $145.75 million.
In an organization with 70 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.19%, operating margin of -129853.42%, and the pretax margin is -121648.72%.
89bio Inc (ETNB) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of 89bio Inc is 4.83%, while institutional ownership is 89.98%. The most recent insider transaction that took place on Jan 30 ’25, was worth 49,999,994. In this transaction Director of this company bought 5,714,285 shares at a rate of $8.75, taking the stock ownership to the 19,554,319 shares. Before that another transaction happened on Jan 22 ’25, when Company’s Director bought 10,000 for $6.71, making the entire transaction worth $67,100. This insider now owns 25,000 shares in total.
89bio Inc (ETNB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -59.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.60% during the next five years compared to -11.24% drop over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
89bio Inc (ETNB) is currently performing well based on its current performance indicators. A quick ratio of 11.65 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.91, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.59 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.53 million. That was inferior than the volume of 2.92 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 43.91%. Additionally, its Average True Range was 0.75.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 84.29%, which indicates a significant increase from 71.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.09% in the past 14 days, which was higher than the 78.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.39, while its 200-day Moving Average is $8.43. However, in the short run, 89bio Inc’s stock first resistance to watch stands at $11.14. Second resistance stands at $11.37. The third major resistance level sits at $11.69. If the price goes on to break the first support level at $10.60, it is likely to go to the next support level at $10.28. The third support level lies at $10.05 if the price breaches the second support level.
89bio Inc (NASDAQ: ETNB) Key Stats
Market capitalization of the company is 1.59 billion based on 106,126K outstanding shares. Right now, sales total 0 K and income totals -142,190 K. The company made 0 K in profit during its latest quarter, and -149,070 K in sales during its previous quarter.
